Chongqing Lummy Pharmaceutical Cash Flow Conversion Efficiency

Latest as of September 2025: -0.008x

Chongqing Lummy Pharmaceutical cash flow conversion efficiency. Based on the latest financial reports, Chongqing Lummy Pharmaceutical (300006) has a cash flow conversion efficiency ratio of -0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-14.90 Million ≈ $-2.18 Million USD) by net assets (CN¥1.85 Billion ≈ $271.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Chongqing Lummy Pharmaceutical (2006–2024)

Cash flow conversion efficiency of Chongqing Lummy Pharmaceutical from 2006 to 2024. This chart illustrates how Chongqing Lummy Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Chongqing Lummy Pharmaceutical share price for real-time trading data and today's change.

Chongqing Lummy Pharmaceutical Cash Flow Conversion Ratio Explained

Chongqing Lummy Pharmaceutical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Chongqing Lummy Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chongqing Lummy Pharmaceutical ranked by their cash flow conversion efficiency. Also see 300006 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Vestjysk Bank A/S CO:VJBA	0.003x
Mobileye Global Inc. Class A Common Stock NASDAQ:MBLY	0.016x
Daqo New Energy Corp ADR NYSE:DQ	-0.025x
AnaptysBio Inc NASDAQ:ANAB	-2.033x
Adecoagro S.A F:ACD	0.067x
Europris ASA OL:EPR	0.341x
Ingersoll Rand (India) Limited NSE:INGERRAND	0.195x
Ultragenyx NASDAQ:RARE	0.342x

Annual Cash Flow Conversion Efficiency for Chongqing Lummy Pharmaceutical (2006–2024)

The table below shows the annual cash flow conversion efficiency of Chongqing Lummy Pharmaceutical from 2006 to 2024. Review Chongqing Lummy Pharmaceutical (300006) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.88 Billion ≈ $275.59 Million	CN¥185.03 Million ≈ $27.08 Million	0.098x	+155.72%
2023-12-31	CN¥2.12 Billion ≈ $310.54 Million	CN¥81.53 Million ≈ $11.93 Million	0.038x	+46.92%
2022-12-31	CN¥2.18 Billion ≈ $319.73 Million	CN¥57.13 Million ≈ $8.36 Million	0.026x	-46.58%
2021-12-31	CN¥2.21 Billion ≈ $323.70 Million	CN¥108.28 Million ≈ $15.84 Million	0.049x	-73.15%
2020-12-31	CN¥1.23 Billion ≈ $180.22 Million	CN¥224.54 Million ≈ $32.86 Million	0.182x	+30.35%
2019-12-31	CN¥1.65 Billion ≈ $241.99 Million	CN¥231.30 Million ≈ $33.85 Million	0.140x	+6.75%
2018-12-31	CN¥1.72 Billion ≈ $252.28 Million	CN¥225.89 Million ≈ $33.05 Million	0.131x	+267.72%
2017-12-31	CN¥1.72 Billion ≈ $252.11 Million	CN¥61.39 Million ≈ $8.98 Million	0.036x	-52.53%
2016-12-31	CN¥1.67 Billion ≈ $245.00 Million	CN¥125.66 Million ≈ $18.39 Million	0.075x	+599.18%
2015-12-31	CN¥1.69 Billion ≈ $247.28 Million	CN¥-25.41 Million ≈ $-3.72 Million	-0.015x	+69.04%
2014-12-31	CN¥1.02 Billion ≈ $148.81 Million	CN¥-49.38 Million ≈ $-7.23 Million	-0.049x	-173.18%
2013-12-31	CN¥1.13 Billion ≈ $164.73 Million	CN¥74.70 Million ≈ $10.93 Million	0.066x	+159.29%
2012-12-31	CN¥710.51 Million ≈ $103.97 Million	CN¥18.18 Million ≈ $2.66 Million	0.026x	+42.56%
2011-12-31	CN¥660.17 Million ≈ $96.60 Million	CN¥11.85 Million ≈ $1.73 Million	0.018x	-73.23%
2010-12-31	CN¥561.59 Million ≈ $82.18 Million	CN¥37.66 Million ≈ $5.51 Million	0.067x	-5.73%
2009-12-31	CN¥525.08 Million ≈ $76.84 Million	CN¥37.35 Million ≈ $5.47 Million	0.071x	-43.18%
2008-12-31	CN¥137.79 Million ≈ $20.16 Million	CN¥17.25 Million ≈ $2.52 Million	0.125x	-37.70%
2007-12-31	CN¥107.91 Million ≈ $15.79 Million	CN¥21.68 Million ≈ $3.17 Million	0.201x	+66.59%
2006-12-31	CN¥64.39 Million ≈ $9.42 Million	CN¥7.77 Million ≈ $1.14 Million	0.121x	--

About Chongqing Lummy Pharmaceutical

SHE:300006 China Drug Manufacturers - General

Market Cap

$1.41 Billion

CN¥9.64 Billion CNY

Market Cap Rank

#7181 Global

#1457 in China

Share Price

CN¥9.13

Change (1 day)

-11.79%

52-Week Range

CN¥4.43 - CN¥10.48

All Time High

CN¥11.34